Pharma - Industry – Focus

 

Custom Search

Suryakiran Labs is expanding its bulk drug unit at Nalagonda


Suryakiran Labs is expanding its bulk drug unit at Dothigudem, Pochampally in Nalagonda district of Andhra Pradesh with an investment of Rs. 22.2 million. A total of 12 Bulk drugs, 5 intermediates products and Piperazine recovery products will be manufactured in this unit with the following details.

S.N.

Products

Quantity (TPA)

Proposed Bulk Drugs

 

1.

Niacinamide

120.0

2.

Itopride Hydrochloride

24.0

3.

Rabeprazole Sodium

36.0

4.

Clopidogrel Hydrogen Bisulfate

36.0

5.

Duloxetine Hydrochloride

12.0

6.

Drotaverine Hydrochloride

12.0

7.

Tamsulosin Hydrochloride

18.0

8.

Mosapride Citrate Dihydrate

12.0

9.

Alfuzosin Hydrochloride

12.0

10.

Omeprazole

36.0

11.

Itraconazole

30.0

12.

Pregabalin

36.0

Proposed Intermediates

1.

(2-Chloro phenyl)-(6,7-dihydro-4H-thieno[3,2-c] pyridin-5-yl) acetic acid methyl ester

18.0

2.

3-Cyano-5-methyl hexanoic acid ethyl ester

12.0

3.

N-Methyl carbo benzyloxy-[(3-naphthalene-1-yl oxy)-3-thiophene-2-yl phenyl] amine

48.0

4.

[2-(4-Amino methyl phenoxy)ethyl] dimethyl amine

24.0

5.

2-[4-(3-Methoxy Propoxy)-3-methyl pyridin-2-yl methyl sulfanyl]-1H-Benzoimidazole

36.0

 

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy